169 related articles for article (PubMed ID: 33217531)
1. A rat subchronic study transcriptional point of departure estimates a carcinogenicity study apical point of departure.
Bianchi E; Costa E; Yan ZJ; Murphy L; Howell J; Anderson D; Mukerji P; Venkatraman A; Terry C; Johnson KJ
Food Chem Toxicol; 2021 Jan; 147():111869. PubMed ID: 33217531
[TBL] [Abstract][Full Text] [Related]
2. A Rat Liver Transcriptomic Point of Departure Predicts a Prospective Liver or Non-liver Apical Point of Departure.
Johnson KJ; Auerbach SS; Costa E
Toxicol Sci; 2020 Jul; 176(1):86-102. PubMed ID: 32384157
[TBL] [Abstract][Full Text] [Related]
3. Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: A case study in the rat with a triazole fungicide.
LaRocca J; Costa E; Sriram S; Hannas BR; Johnson KJ
Regul Toxicol Pharmacol; 2020 Jun; 113():104655. PubMed ID: 32268158
[TBL] [Abstract][Full Text] [Related]
4. Recommended approaches in the application of toxicogenomics to derive points of departure for chemical risk assessment.
Farmahin R; Williams A; Kuo B; Chepelev NL; Thomas RS; Barton-Maclaren TS; Curran IH; Nong A; Wade MG; Yauk CL
Arch Toxicol; 2017 May; 91(5):2045-2065. PubMed ID: 27928627
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of carcinogenicity predictors from short-term and sub chronic repeat-dose studies of agrochemicals in rats: Opportunities to refine and reduce animal use.
Mistry P; McInnes EF; Beevers C; Wolf D; Currie RA; Salimraj R; Parsons P
Toxicol Lett; 2021 Oct; 351():18-27. PubMed ID: 34364947
[TBL] [Abstract][Full Text] [Related]
6. A microRNA or messenger RNA point of departure estimates an apical endpoint point of departure in a rat developmental toxicity model.
Johnson KJ; Costa E; Marshall V; Sriram S; Venkatraman A; Stebbins K; LaRocca J
Birth Defects Res; 2022 Jul; 114(11):559-576. PubMed ID: 35596682
[TBL] [Abstract][Full Text] [Related]
7. Assessing human carcinogenicity risk of agrochemicals without the rodent cancer bioassay.
Goetz A; Ryan N; Sauve-Ciencewicki A; Lord CC; Hilton GM; Wolf DC
Front Toxicol; 2024; 6():1394361. PubMed ID: 38933090
[TBL] [Abstract][Full Text] [Related]
8. Rethinking chronic toxicity and carcinogenicity assessment for agrochemicals project (ReCAAP): A reporting framework to support a weight of evidence safety assessment without long-term rodent bioassays.
Hilton GM; Adcock C; Akerman G; Baldassari J; Battalora M; Casey W; Clippinger AJ; Cope R; Goetz A; Hayes AW; Papineni S; Peffer RC; Ramsingh D; Williamson Riffle B; Sanches da Rocha M; Ryan N; Scollon E; Visconti N; Wolf DC; Yan Z; Lowit A
Regul Toxicol Pharmacol; 2022 Jun; 131():105160. PubMed ID: 35311659
[TBL] [Abstract][Full Text] [Related]
9. Impact of Genomics Platform and Statistical Filtering on Transcriptional Benchmark Doses (BMD) and Multiple Approaches for Selection of Chemical Point of Departure (PoD).
Webster AF; Chepelev N; Gagné R; Kuo B; Recio L; Williams A; Yauk CL
PLoS One; 2015; 10(8):e0136764. PubMed ID: 26313361
[TBL] [Abstract][Full Text] [Related]
10. Towards achieving a modern science-based paradigm for agrochemical carcinogenicity assessment.
Hilton GM; Corvi R; Luijten M; Mehta J; Wolf DC
Regul Toxicol Pharmacol; 2023 Jan; 137():105301. PubMed ID: 36436696
[TBL] [Abstract][Full Text] [Related]
11. Temporal concordance between apical and transcriptional points of departure for chemical risk assessment.
Thomas RS; Wesselkamper SC; Wang NC; Zhao QJ; Petersen DD; Lambert JC; Cote I; Yang L; Healy E; Black MB; Clewell HJ; Allen BC; Andersen ME
Toxicol Sci; 2013 Jul; 134(1):180-94. PubMed ID: 23596260
[TBL] [Abstract][Full Text] [Related]
12. Towards a mechanism-based approach for the prediction of nongenotoxic carcinogenic potential of agrochemicals.
Heusinkveld H; Braakhuis H; Gommans R; Botham P; Corvaro M; van der Laan JW; Lewis D; Madia F; Manou I; Schorsch F; Wolterink G; Woutersen R; Corvi R; Mehta J; Luijten M
Crit Rev Toxicol; 2020 Oct; 50(9):725-739. PubMed ID: 33236972
[TBL] [Abstract][Full Text] [Related]
13. Application of transcriptional benchmark dose values in quantitative cancer and noncancer risk assessment.
Thomas RS; Clewell HJ; Allen BC; Wesselkamper SC; Wang NC; Lambert JC; Hess-Wilson JK; Zhao QJ; Andersen ME
Toxicol Sci; 2011 Mar; 120(1):194-205. PubMed ID: 21097997
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of 5-day In Vivo Rat Liver and Kidney With High-throughput Transcriptomics for Estimating Benchmark Doses of Apical Outcomes.
Gwinn WM; Auerbach SS; Parham F; Stout MD; Waidyanatha S; Mutlu E; Collins B; Paules RS; Merrick BA; Ferguson S; Ramaiahgari S; Bucher JR; Sparrow B; Toy H; Gorospe J; Machesky N; Shah RR; Balik-Meisner MR; Mav D; Phadke DP; Roberts G; DeVito MJ
Toxicol Sci; 2020 Aug; 176(2):343-354. PubMed ID: 32492150
[TBL] [Abstract][Full Text] [Related]
15. Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop.
Felter SP; Bhat VS; Botham PA; Bussard DA; Casey W; Hayes AW; Hilton GM; Magurany KA; Sauer UG; Ohanian EV
Crit Rev Toxicol; 2021 Sep; 51(8):653-694. PubMed ID: 35239444
[TBL] [Abstract][Full Text] [Related]
16. Toxicogenomics and cancer risk assessment: a framework for key event analysis and dose-response assessment for nongenotoxic carcinogens.
Bercu JP; Jolly RA; Flagella KM; Baker TK; Romero P; Stevens JL
Regul Toxicol Pharmacol; 2010 Dec; 58(3):369-81. PubMed ID: 20801182
[TBL] [Abstract][Full Text] [Related]
17. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
18. Toxicogenomic assessment of liver responses following subchronic exposure to furan in Fischer F344 rats.
Dong H; Gill S; Curran IH; Williams A; Kuo B; Wade MG; Yauk CL
Arch Toxicol; 2016 Jun; 90(6):1351-67. PubMed ID: 26194646
[TBL] [Abstract][Full Text] [Related]
19. Concordance of transcriptional and apical benchmark dose levels for conazole-induced liver effects in mice.
Bhat VS; Hester SD; Nesnow S; Eastmond DA
Toxicol Sci; 2013 Nov; 136(1):205-15. PubMed ID: 23970803
[TBL] [Abstract][Full Text] [Related]
20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
